社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
花里胡哨的
IP属地:上海
+关注
帖子 · 19
帖子 · 19
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
花里胡哨的
花里胡哨的
·
07-10
不买了?
非常抱歉,此主贴已删除
看
156
回复
评论
点赞
1
编组 21备份 2
分享
举报
花里胡哨的
花里胡哨的
·
07-10
$Enigmatig Limited(EGG)$
怎么回事停牌那么久
看
638
回复
评论
点赞
1
编组 21备份 2
分享
举报
花里胡哨的
花里胡哨的
·
07-09
$ProKidney Corp.(PROK)$
都别卖把价格顶到10块
看
1,370
回复
6
点赞
3
编组 21备份 2
分享
举报
花里胡哨的
花里胡哨的
·
07-09
$PROK 20250718 2.5 CALL$
看涨20
看
1,830
回复
5
点赞
3
编组 21备份 2
分享
举报
花里胡哨的
花里胡哨的
·
07-09
$ProKidney Corp.(PROK)$
下一个脑再生20块有希望 ProKidney Corp.(纳斯达克:PROK)是一家专注于开发治疗慢性肾病(CKD)的细胞疗法的生物技术公司,其股价近期出现大幅上涨,主要原因包括以下几个方面: 1. 积极的临床试验结果 • 2期REGEN-007试验的突破性数据:2025年7月8日,ProKidney公布了其2期临床试验的顶线结果,显示其核心产品Rilparencel(REACT™)在治疗慢性肾病合并糖尿病患者中表现出显著的疗效。第一组患者的eGFR(肾小球滤过率)年下降率改善了78%,具有统计学和临床意义(p<0.001)。 • 剂量反应趋势:第二组患者虽然未达到统计学显著性(p=0.085),但仍显示出剂量反应趋势,增强了市场对3期试验成功的信心。 2. 加速审批的可能性 • FDA的积极反馈:ProKidney在2024年第四季度与FDA进行了B类会议,确认如果采用eGFR斜率作为替代终点,其产品可能符合加速审批资格。公司计划在2025年夏季进一步与FDA讨论这一方案。 • RMAT(再生医学先进疗法)认定:Rilparencel已获得FDA的RMAT认定,这有助于加快其开发和审批流程。 3. 市场潜力与未满足的医疗需求 • 庞大的目标患者群体:ProKidney专注于3b/4期CKD合并糖尿病患者,预计覆盖美国100-200万患者,这一领域目前缺乏有效治疗手段。 • 商业化前景:如果获批,Rilparencel将成为首个能够稳定甚至改善晚期CKD患者肾功能的疗法,市场潜力巨大。 4. 财务稳定性 • 充足的现金储备:截至2024年第三季度,公司现金储备为4.068亿美元,足以支持运营至2027年,降低了短期融资风险。 • 亏损收窄:2
看
3,380
回复
评论
点赞
5
编组 21备份 2
分享
举报
花里胡哨的
花里胡哨的
·
07-09
$PROK 20250718 2.5 CALL$
别人恐惧我贪婪加仓
看
828
回复
1
点赞
1
编组 21备份 2
分享
举报
花里胡哨的
花里胡哨的
·
07-03
$脑再生科技(RGC)$
这玩意也有期权。。。。
看
495
回复
评论
点赞
3
编组 21备份 2
分享
举报
花里胡哨的
花里胡哨的
·
06-27
$Blue Gold Ltd(BGL)$
这个干嘛的公司
看
1,546
回复
2
点赞
3
编组 21备份 2
分享
举报
花里胡哨的
花里胡哨的
·
06-27
$小米集团-W(01810)$
搞他吗什么拉高出货艹
看
353
回复
评论
点赞
1
编组 21备份 2
分享
举报
花里胡哨的
花里胡哨的
·
06-26
一路跌还调整
非常抱歉,此主贴已删除
看
598
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
暂无粉丝
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4205162645130852","uuid":"4205162645130852","gmtCreate":1742956424632,"gmtModify":1744798463832,"name":"花里胡哨的","pinyin":"hlhsdhualihushaode","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/65a35fbac6df2b787ca45549f5fec87d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":31,"tweetSize":19,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":4,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.29","exceedPercentage":"93.66%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.29","exceedPercentage":"93.70%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.03.27","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":9,"crmLevelSwitch":0,"location":"上海","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":8,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":455131894260024,"gmtCreate":1752153149787,"gmtModify":1752153151344,"author":{"id":"4205162645130852","authorId":"4205162645130852","name":"花里胡哨的","avatar":"https://static.tigerbbs.com/65a35fbac6df2b787ca45549f5fec87d","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4205162645130852","authorIdStr":"4205162645130852"},"themes":[],"htmlText":"不买了?","listText":"不买了?","text":"不买了?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/455131894260024","repostId":"2550623394","repostType":2,"isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":454908798529664,"gmtCreate":1752080059447,"gmtModify":1752080060426,"author":{"id":"4205162645130852","authorId":"4205162645130852","name":"花里胡哨的","avatar":"https://static.tigerbbs.com/65a35fbac6df2b787ca45549f5fec87d","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4205162645130852","authorIdStr":"4205162645130852"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/EGG\">$Enigmatig Limited(EGG)$</a> 怎么回事停牌那么久","listText":"<a href=\"https://laohu8.com/S/EGG\">$Enigmatig Limited(EGG)$</a> 怎么回事停牌那么久","text":"$Enigmatig Limited(EGG)$ 怎么回事停牌那么久","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/454908798529664","isVote":1,"tweetType":1,"viewCount":638,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":454871710130216,"gmtCreate":1752070699495,"gmtModify":1752070700694,"author":{"id":"4205162645130852","authorId":"4205162645130852","name":"花里胡哨的","avatar":"https://static.tigerbbs.com/65a35fbac6df2b787ca45549f5fec87d","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4205162645130852","authorIdStr":"4205162645130852"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PROK\">$ProKidney Corp.(PROK)$</a> 都别卖把价格顶到10块","listText":"<a href=\"https://laohu8.com/S/PROK\">$ProKidney Corp.(PROK)$</a> 都别卖把价格顶到10块","text":"$ProKidney Corp.(PROK)$ 都别卖把价格顶到10块","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/454871710130216","isVote":1,"tweetType":1,"viewCount":1370,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3494729537899364","authorId":"3494729537899364","name":"早A晚美","avatar":"https://static.tigerbbs.com/2fe8285ec788e197ca37c0047be75bd4","crmLevel":6,"crmLevelSwitch":1,"idStr":"3494729537899364","authorIdStr":"3494729537899364"},"content":"今天有点腥风血雨","text":"今天有点腥风血雨","html":"今天有点腥风血雨"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":454502070583632,"gmtCreate":1752000643278,"gmtModify":1752000645443,"author":{"id":"4205162645130852","authorId":"4205162645130852","name":"花里胡哨的","avatar":"https://static.tigerbbs.com/65a35fbac6df2b787ca45549f5fec87d","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4205162645130852","authorIdStr":"4205162645130852"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/OPT/PROK 20250718 2.5 CALL\">$PROK 20250718 2.5 CALL$</a> 看涨20","listText":"<a href=\"https://laohu8.com/OPT/PROK 20250718 2.5 CALL\">$PROK 20250718 2.5 CALL$</a> 看涨20","text":"$PROK 20250718 2.5 CALL$ 看涨20","images":[{"img":"https://static.tigerbbs.com/738ff23bc63e6dee840169e2b2850223","width":"1122","height":"1737"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/454502070583632","isVote":1,"tweetType":1,"viewCount":1830,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3494729537899364","authorId":"3494729537899364","name":"早A晚美","avatar":"https://static.tigerbbs.com/2fe8285ec788e197ca37c0047be75bd4","crmLevel":6,"crmLevelSwitch":1,"idStr":"3494729537899364","authorIdStr":"3494729537899364"},"content":"期权怎么买卖的?看不懂","text":"期权怎么买卖的?看不懂","html":"期权怎么买卖的?看不懂"}],"imageCount":1,"langContent":"CN","totalScore":0},{"id":454484537663536,"gmtCreate":1751995825835,"gmtModify":1751997602930,"author":{"id":"4205162645130852","authorId":"4205162645130852","name":"花里胡哨的","avatar":"https://static.tigerbbs.com/65a35fbac6df2b787ca45549f5fec87d","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4205162645130852","authorIdStr":"4205162645130852"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PROK\">$ProKidney Corp.(PROK)$</a> 下一个脑再生20块有希望 ProKidney Corp.(纳斯达克:PROK)是一家专注于开发治疗慢性肾病(CKD)的细胞疗法的生物技术公司,其股价近期出现大幅上涨,主要原因包括以下几个方面: 1. 积极的临床试验结果 • 2期REGEN-007试验的突破性数据:2025年7月8日,ProKidney公布了其2期临床试验的顶线结果,显示其核心产品Rilparencel(REACT™)在治疗慢性肾病合并糖尿病患者中表现出显著的疗效。第一组患者的eGFR(肾小球滤过率)年下降率改善了78%,具有统计学和临床意义(p<0.001)。 • 剂量反应趋势:第二组患者虽然未达到统计学显著性(p=0.085),但仍显示出剂量反应趋势,增强了市场对3期试验成功的信心。 2. 加速审批的可能性 • FDA的积极反馈:ProKidney在2024年第四季度与FDA进行了B类会议,确认如果采用eGFR斜率作为替代终点,其产品可能符合加速审批资格。公司计划在2025年夏季进一步与FDA讨论这一方案。 • RMAT(再生医学先进疗法)认定:Rilparencel已获得FDA的RMAT认定,这有助于加快其开发和审批流程。 3. 市场潜力与未满足的医疗需求 • 庞大的目标患者群体:ProKidney专注于3b/4期CKD合并糖尿病患者,预计覆盖美国100-200万患者,这一领域目前缺乏有效治疗手段。 • 商业化前景:如果获批,Rilparencel将成为首个能够稳定甚至改善晚期CKD患者肾功能的疗法,市场潜力巨大。 4. 财务稳定性 • 充足的现金储备:截至2024年第三季度,公司现金储备为4.068亿美元,足以支持运营至2027年,降低了短期融资风险。 • 亏损收窄:2","listText":"<a href=\"https://laohu8.com/S/PROK\">$ProKidney Corp.(PROK)$</a> 下一个脑再生20块有希望 ProKidney Corp.(纳斯达克:PROK)是一家专注于开发治疗慢性肾病(CKD)的细胞疗法的生物技术公司,其股价近期出现大幅上涨,主要原因包括以下几个方面: 1. 积极的临床试验结果 • 2期REGEN-007试验的突破性数据:2025年7月8日,ProKidney公布了其2期临床试验的顶线结果,显示其核心产品Rilparencel(REACT™)在治疗慢性肾病合并糖尿病患者中表现出显著的疗效。第一组患者的eGFR(肾小球滤过率)年下降率改善了78%,具有统计学和临床意义(p<0.001)。 • 剂量反应趋势:第二组患者虽然未达到统计学显著性(p=0.085),但仍显示出剂量反应趋势,增强了市场对3期试验成功的信心。 2. 加速审批的可能性 • FDA的积极反馈:ProKidney在2024年第四季度与FDA进行了B类会议,确认如果采用eGFR斜率作为替代终点,其产品可能符合加速审批资格。公司计划在2025年夏季进一步与FDA讨论这一方案。 • RMAT(再生医学先进疗法)认定:Rilparencel已获得FDA的RMAT认定,这有助于加快其开发和审批流程。 3. 市场潜力与未满足的医疗需求 • 庞大的目标患者群体:ProKidney专注于3b/4期CKD合并糖尿病患者,预计覆盖美国100-200万患者,这一领域目前缺乏有效治疗手段。 • 商业化前景:如果获批,Rilparencel将成为首个能够稳定甚至改善晚期CKD患者肾功能的疗法,市场潜力巨大。 4. 财务稳定性 • 充足的现金储备:截至2024年第三季度,公司现金储备为4.068亿美元,足以支持运营至2027年,降低了短期融资风险。 • 亏损收窄:2","text":"$ProKidney Corp.(PROK)$ 下一个脑再生20块有希望 ProKidney Corp.(纳斯达克:PROK)是一家专注于开发治疗慢性肾病(CKD)的细胞疗法的生物技术公司,其股价近期出现大幅上涨,主要原因包括以下几个方面: 1. 积极的临床试验结果 • 2期REGEN-007试验的突破性数据:2025年7月8日,ProKidney公布了其2期临床试验的顶线结果,显示其核心产品Rilparencel(REACT™)在治疗慢性肾病合并糖尿病患者中表现出显著的疗效。第一组患者的eGFR(肾小球滤过率)年下降率改善了78%,具有统计学和临床意义(p<0.001)。 • 剂量反应趋势:第二组患者虽然未达到统计学显著性(p=0.085),但仍显示出剂量反应趋势,增强了市场对3期试验成功的信心。 2. 加速审批的可能性 • FDA的积极反馈:ProKidney在2024年第四季度与FDA进行了B类会议,确认如果采用eGFR斜率作为替代终点,其产品可能符合加速审批资格。公司计划在2025年夏季进一步与FDA讨论这一方案。 • RMAT(再生医学先进疗法)认定:Rilparencel已获得FDA的RMAT认定,这有助于加快其开发和审批流程。 3. 市场潜力与未满足的医疗需求 • 庞大的目标患者群体:ProKidney专注于3b/4期CKD合并糖尿病患者,预计覆盖美国100-200万患者,这一领域目前缺乏有效治疗手段。 • 商业化前景:如果获批,Rilparencel将成为首个能够稳定甚至改善晚期CKD患者肾功能的疗法,市场潜力巨大。 4. 财务稳定性 • 充足的现金储备:截至2024年第三季度,公司现金储备为4.068亿美元,足以支持运营至2027年,降低了短期融资风险。 • 亏损收窄:2","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/454484537663536","isVote":1,"tweetType":1,"viewCount":3380,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":454482173428224,"gmtCreate":1751995420220,"gmtModify":1751995422480,"author":{"id":"4205162645130852","authorId":"4205162645130852","name":"花里胡哨的","avatar":"https://static.tigerbbs.com/65a35fbac6df2b787ca45549f5fec87d","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4205162645130852","authorIdStr":"4205162645130852"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/OPT/PROK 20250718 2.5 CALL\">$PROK 20250718 2.5 CALL$</a> 别人恐惧我贪婪加仓","listText":"<a href=\"https://laohu8.com/OPT/PROK 20250718 2.5 CALL\">$PROK 20250718 2.5 CALL$</a> 别人恐惧我贪婪加仓","text":"$PROK 20250718 2.5 CALL$ 别人恐惧我贪婪加仓","images":[{"img":"https://static.tigerbbs.com/dda6afe80f237c37e72fe71617c5bf32","width":"1122","height":"1737"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/454482173428224","isVote":1,"tweetType":1,"viewCount":828,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":452727858614296,"gmtCreate":1751555217126,"gmtModify":1751555218247,"author":{"id":"4205162645130852","authorId":"4205162645130852","name":"花里胡哨的","avatar":"https://static.tigerbbs.com/65a35fbac6df2b787ca45549f5fec87d","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4205162645130852","authorIdStr":"4205162645130852"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RGC\">$脑再生科技(RGC)$ </a> 这玩意也有期权。。。。","listText":"<a href=\"https://laohu8.com/S/RGC\">$脑再生科技(RGC)$ </a> 这玩意也有期权。。。。","text":"$脑再生科技(RGC)$ 这玩意也有期权。。。。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/452727858614296","isVote":1,"tweetType":1,"viewCount":495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":450509948383336,"gmtCreate":1751013295665,"gmtModify":1751013299382,"author":{"id":"4205162645130852","authorId":"4205162645130852","name":"花里胡哨的","avatar":"https://static.tigerbbs.com/65a35fbac6df2b787ca45549f5fec87d","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4205162645130852","authorIdStr":"4205162645130852"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BGL\">$Blue Gold Ltd(BGL)$</a> 这个干嘛的公司","listText":"<a href=\"https://laohu8.com/S/BGL\">$Blue Gold Ltd(BGL)$</a> 这个干嘛的公司","text":"$Blue Gold Ltd(BGL)$ 这个干嘛的公司","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/450509948383336","isVote":1,"tweetType":1,"viewCount":1546,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4096466110857550","authorId":"4096466110857550","name":"稳扎稳打做交易暴利短暂","avatar":"https://static.tigerbbs.com/3180f85b3f9559e18b13c28b228adaf8","crmLevel":8,"crmLevelSwitch":1,"idStr":"4096466110857550","authorIdStr":"4096466110857550"},"content":"采集金矿的 这个价位拉这么高!无量不跟","text":"采集金矿的 这个价位拉这么高!无量不跟","html":"采集金矿的 这个价位拉这么高!无量不跟"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":450407226790472,"gmtCreate":1750991205796,"gmtModify":1750992094209,"author":{"id":"4205162645130852","authorId":"4205162645130852","name":"花里胡哨的","avatar":"https://static.tigerbbs.com/65a35fbac6df2b787ca45549f5fec87d","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4205162645130852","authorIdStr":"4205162645130852"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$ </a> 搞他吗什么拉高出货艹","listText":"<a href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$ </a> 搞他吗什么拉高出货艹","text":"$小米集团-W(01810)$ 搞他吗什么拉高出货艹","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/450407226790472","isVote":1,"tweetType":1,"viewCount":353,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":450222999568736,"gmtCreate":1750946614081,"gmtModify":1750946615893,"author":{"id":"4205162645130852","authorId":"4205162645130852","name":"花里胡哨的","avatar":"https://static.tigerbbs.com/65a35fbac6df2b787ca45549f5fec87d","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4205162645130852","authorIdStr":"4205162645130852"},"themes":[],"htmlText":"一路跌还调整","listText":"一路跌还调整","text":"一路跌还调整","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/450222999568736","repostId":"2546394627","repostType":2,"isVote":1,"tweetType":1,"viewCount":598,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}